A detailed history of Capital Counsel LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Counsel LLC holds 292 shares of LLY stock, worth $224,185. This represents 0.01% of its overall portfolio holdings.

Number of Shares
292
Previous 285 2.46%
Holding current value
$224,185
Previous $258,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $5,404 - $6,720
7 Added 2.46%
292 $258,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $168,777 - $225,799
285 New
285 $221,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Counsel LLC Portfolio

Follow Capital Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Counsel LLC with notifications on news.